{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T02:21:58Z","timestamp":1648866118612},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"23-24","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Wien Klin Wochenschr"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1007\/s00508-013-0481-5","type":"journal-article","created":{"date-parts":[[2013,12,13]],"date-time":"2013-12-13T11:51:30Z","timestamp":1386935490000},"page":"766-775","source":"Crossref","is-referenced-by-count":0,"title":["Almanac 2013: novel non-coronary cardiac interventions"],"prefix":"10.1007","volume":"125","author":[{"given":"Pascal","family":"Meier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olaf","family":"Franzen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra J.","family":"Lansky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,12,14]]},"reference":[{"key":"481_CR1","first-page":"91","volume":"13","author":"P Meier","year":"2012","unstructured":"Meier P, Timmis A. Almanac 2012: interventional cardiology. Anadolu Kardiyol Derg. 2012;13:91\u2013101.","journal-title":"Anadolu Kardiyol Derg"},{"key":"481_CR2","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1161\/01.CIR.0000140263.20897.42","volume":"110","author":"DM Lloyd-Jones","year":"2004","unstructured":"Lloyd-Jones DM, Wang TJ, Leip EP, et al. Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. Circulation. 2004;110:1042\u20136.","journal-title":"Circulation"},{"key":"481_CR3","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1093\/eurheartj\/ehq278","volume":"31","author":"AJ Camm","year":"2010","unstructured":"European Heart Rhythm Association, European Association for Cardio-Thoracic Surgery, Camm AJ, et al. Guidelines for the management of atrial fibrillation: the task force for the management of atrial fibrillation of the European Society of Cardiology (ESC). Eur Heart J. 2010;31:2369\u2013429.","journal-title":"Eur Heart J"},{"key":"481_CR4","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1111\/j.1538-7836.2008.03059.x","volume":"6","author":"AM Gallagher","year":"2008","unstructured":"Gallagher AM, Rietbrock S, Plumb J, et al. Initiation and persistence of warfarin or aspirin in patients with chronic atrial fibrillation in general practice: do the appropriate patients receive stroke prophylaxis? J Thromb Haemost. 2008;6:1500\u20136.","journal-title":"J Thromb Haemost"},{"key":"481_CR5","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/S0735-1097(03)00954-9","volume":"42","author":"MA Garcia-Fernandez","year":"2003","unstructured":"Garcia-Fernandez MA, Perez-David E, Quiles J, et al. Role of left atrial appendage obliteration in stroke reduction in patients with mitral valve prosthesis: a transesophageal echocardiographic study. J Am Coll Cardiol. 2003;42:1253\u20138.","journal-title":"J Am Coll Cardiol"},{"key":"481_CR6","doi-asserted-by":"crossref","first-page":"e523","DOI":"10.1161\/CIRCULATIONAHA.108.190748","volume":"118","author":"WC MEMBERS","year":"2008","unstructured":"MEMBERS WC, Bonow RO, Carabello BA, et al. Focused update incorporated into the ACC\/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation. 2008;118:e523\u2013661.","journal-title":"Circulation"},{"key":"481_CR7","doi-asserted-by":"crossref","unstructured":"Khattab AA, Meier B. Transcatheter left atrial appendage exclusion, gold or fool\u2019s gold? Eur Heart J Suppl. 2010;12:E35\u201340.","DOI":"10.1093\/eurheartj\/suq008"},{"key":"481_CR8","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1161\/01.CIR.0000153802.70682.22","volume":"111","author":"JE Sousa","year":"2005","unstructured":"Sousa JE, Costa MA, Tuzcu EM, et al. New frontiers in interventional cardiology. Circulation. 2005;111:671\u201381.","journal-title":"Circulation"},{"key":"481_CR9","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1136\/heartjnl-2011-301256","volume":"98","author":"S Munkholm-Larsen","year":"2012","unstructured":"Munkholm-Larsen S, Cao C, Yan TD, et al. Percutaneous atrial appendage occlusion for stroke prevention in patients with atrial fibrillation: a systematic review. Heart. 2012;98:900\u20137.","journal-title":"Heart"},{"key":"481_CR10","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S0140-6736(09)61343-X","volume":"374","author":"DR Holmes","year":"2009","unstructured":"Holmes DR, Reddy VY, Turi ZG, et al. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial. Lancet. 2009;374:534\u201342.","journal-title":"Lancet"},{"key":"481_CR11","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1161\/CIRCULATIONAHA.112.114389","volume":"127","author":"VY Reddy","year":"2013","unstructured":"Reddy VY, Doshi SK, Sievert H, et al. Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation: 2.3-year follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patients with Atrial Fibrillation) Trial. Circulation. 2013;127:720\u20139.","journal-title":"Circulation"},{"key":"481_CR12","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1161\/CIRCULATIONAHA.110.976449","volume":"123","author":"VY Reddy","year":"2011","unstructured":"Reddy VY, Holmes D, Doshi SK, et al. Safety of percutaneous left atrial appendage closure: results from the Watchman Left Atrial Appendage System for Embolic Protection in Patients with AF (PROTECT AF) clinical trial and the Continued Access Registry. Circulation. 2011;123:417\u201324.","journal-title":"Circulation"},{"key":"481_CR13","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.amjcard.2012.11.061","volume":"111","author":"A Massumi","year":"2013","unstructured":"Massumi A, Chelu MG, Nazeri A, et al. Initial experience with a novel percutaneous left atrial appendage exclusion device in patients with atrial fibrillation, increased stroke risk, and contraindications to anticoagulation. Am J Cardiol. 2013;111:869\u201373.","journal-title":"Am J Cardiol"},{"key":"481_CR14","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.jacc.2011.11.028","volume":"59","author":"JF Viles-Gonzalez","year":"2012","unstructured":"Viles-Gonzalez JF, Kar S, Douglas P, et al. The clinical impact of incomplete left atrial appendage closure with the Watchman Device in patients with atrial fibrillation: a PROTECT AF (Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patients With Atrial Fibrillation) substudy. J Am Coll Cardiol. 2012;59:923\u20139.","journal-title":"J Am Coll Cardiol"},{"key":"481_CR15","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/ccd.22536","volume":"76","author":"JL Bass","year":"2010","unstructured":"Bass JL. Transcatheter occlusion of the left atrial appendage\u2013experimental testing of a new amplatzer device. Catheter Cardiovasc Interv. 2010;76:181\u20135.","journal-title":"Catheter Cardiovasc Interv"},{"key":"481_CR16","doi-asserted-by":"crossref","first-page":"e7498","DOI":"10.1136\/bmj.e7498","volume":"345","author":"BD Fox","year":"2012","unstructured":"Fox BD, Kahn SR, Langleben D, et al. Efficacy and safety of novel oral anticoagulants for treatment of acute venous thromboembolism: direct and adjusted indirect meta-analysis of randomised controlled trials. BMJ. 2012;345:e7498.","journal-title":"BMJ"},{"key":"481_CR17","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1093\/eurheartj\/ehs253","volume":"33","author":"AJ Camm","year":"2012","unstructured":"Camm AJ, Lip GY, De Caterina R, et al. 2012 focused update of the ESC guidelines for the management of atrial fibrillation: an update of the 2010 ESC guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J. 2012;33:2719\u201347.","journal-title":"Eur Heart J"},{"key":"481_CR18","doi-asserted-by":"crossref","unstructured":"Iung B, Vahanian A. Degenerative calcific aortic stenosis: a natural history. Heart. 2012;98:iv7\u201313.","DOI":"10.1136\/heartjnl-2012-302395"},{"key":"481_CR19","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.ejcts.2011.01.017","volume":"39","author":"O Alfieri","year":"2011","unstructured":"Alfieri O, Denti P. Alfieri stitch and its impact on mitral clip. Eur J Cardiothorac Surg. 2011;39:807\u20138.","journal-title":"Eur J Cardiothorac Surg"},{"key":"481_CR20","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1136\/hrt.2011.227785","volume":"97","author":"V Delgado","year":"2011","unstructured":"Delgado V, Kapadia S, Marsan NA, et al. Multimodality imaging before, during, and after percutaneous mitral valve repair. Heart. 2011;97:1704\u201314.","journal-title":"Heart"},{"key":"481_CR21","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1016\/j.jacc.2005.07.065","volume":"46","author":"T Feldman","year":"2005","unstructured":"Feldman T, Wasserman HS, Herrmann HC, et al. Percutaneous mitral valve repair using the edge-to-edge technique: six-month results of the EVEREST phase I clinical trial. J Am Coll Cardiol. 2005;46:2134\u201340.","journal-title":"J Am Coll Cardiol"},{"key":"481_CR22","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1056\/NEJMoa1009355","volume":"364","author":"T Feldman","year":"2011","unstructured":"Feldman T, Foster E, Glower DD, et al. Percutaneous repair or surgery for mitral regurgitation. N Engl J Med. 2011;364:1395\u2013406.","journal-title":"N Engl J Med"},{"key":"481_CR23","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jacc.2011.08.067","volume":"59","author":"PL Whitlow","year":"2012","unstructured":"Whitlow PL, Feldman T, Pedersen WR, et al. Acute and 12-month results with catheter-based mitral valve leaflet repair: the EVEREST II (endovascular valve edge-to-edge repair) high risk study. J Am Coll Cardiol. 2012;59:130\u20139.","journal-title":"J Am Coll Cardiol"},{"key":"481_CR24","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.jacc.2009.03.077","volume":"54","author":"T Feldman","year":"2009","unstructured":"Feldman T, Kar S, Rinaldi M, et al. Percutaneous mitral repair with the MitraClip system: safety and midterm durability in the initial EVEREST (Endovascular Valve Edge-to-Edge REpair Study) cohort. J Am Coll Cardiol. 2009;54:686\u201394.","journal-title":"J Am Coll Cardiol"},{"key":"481_CR25","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1093\/eurheartj\/ehq051","volume":"31","author":"C Tamburino","year":"2010","unstructured":"Tamburino C, Ussia GP, Maisano F, et al. Percutaneous mitral valve repair with the MitraClip system: acute results from a real world setting. Eur Heart J. 2010;31:1382\u20139.","journal-title":"Eur Heart J"},{"key":"481_CR26","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1136\/heartjnl-2012-303105","volume":"99","author":"D S\u00fcrder","year":"2013","unstructured":"S\u00fcrder D, Pedrazzini G, Gaemperli O, et al. Predictors for efficacy of percutaneous mitral valve repair using the MitraClip system: the results of the MitraSwiss registry. Heart. 2013;99:1034\u201340.","journal-title":"Heart"},{"key":"481_CR27","unstructured":"Kar S, Rinaldi M, Lim DS, et al. EVEREST II REALISM: a continued access study to evaluate the safety and effectiveness of the MitraClip device: demographics and procedural outcomes. Baltimore: Society for Cardiovascular Angiography and Interventions (SCAI) 2011 Scientific Sessions; 2011."},{"key":"481_CR28","unstructured":"Rinaldi MJ, Kar S, Lim DS, et al. EVEREST II REALISM: a continued access study to evaluate the safety and effectiveness of the MitraClip device: analysis of a 6\u00a0month patient cohort. Baltimore: Society for Cardiovascular Angiography and Interventions (SCAI) 2011 Scientific Sessions; 2011."},{"key":"481_CR29","unstructured":"Sarkar K, Ussia GP, Cammalleri V, et al. Quality of life of high risk patients following percutaneous mitral valve repair with the MitraClip system. Baltimore: Society for Cardiovascular Angiography and Interventions (SCAI) 2011 Scientific Sessions; 2011."},{"key":"481_CR30","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1136\/heartjnl-2011-300705","volume":"98","author":"O Gaemperli","year":"2012","unstructured":"Gaemperli O, Moccetti M, Surder D, et al. Acute haemodynamic changes after percutaneous mitral valve repair: relation to mid-term outcomes. Heart. 2012;98:126\u201332.","journal-title":"Heart"},{"key":"481_CR31","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1136\/hrt.2010.202432","volume":"97","author":"Z Samad","year":"2011","unstructured":"Samad Z, Kaul P, Shaw LK, et al. Impact of early surgery on survival of patients with severe mitral regurgitation. Heart. 2011;97:221\u20134.","journal-title":"Heart"},{"key":"481_CR32","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0140-6736(06)69208-8","volume":"368","author":"VT Nkomo","year":"2006","unstructured":"Nkomo VT, Gardin JM, Skelton TN, et al. Burden of valvular heart diseases: a population-based study. Lancet. 2006;368:1005\u201311.","journal-title":"Lancet"},{"key":"481_CR33","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1136\/heartjnl-2011-301396","volume":"97","author":"R Rosenhek","year":"2011","unstructured":"Rosenhek R. Almanac 2011: valvular heart disease. The national society journals present selected research that has driven recent advances in clinical cardiology. Heart. 2011;97:2007\u201317.","journal-title":"Heart"},{"key":"481_CR34","doi-asserted-by":"crossref","first-page":"iv65","DOI":"10.1136\/heartjnl-2012-302393","volume":"98","author":"J-M Sinning","year":"2012","unstructured":"Sinning J-M, Werner N, Nickenig G, et al. Transcatheter aortic valve implantation: the evidence. Heart. 2012;98:iv65\u201372.","journal-title":"Heart"},{"key":"481_CR35","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.jtcvs.2012.07.021","volume":"144","author":"A Agnihotri","year":"2012","unstructured":"Agnihotri A. ACCF\/AATS\/SCAI\/STS expert consensus document on transcatheter aortic valve replacement: executive summary. J Thorac Cardiovasc Surg. 2012;144:534\u20137.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"481_CR36","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1136\/heartjnl-2011-300444","volume":"98","author":"M Watt","year":"2012","unstructured":"Watt M, Mealing S, Eaton J, et al. Cost-effectiveness of transcatheter aortic valve replacement in patients ineligible for conventional aortic valve replacement. Heart. 2012;98:370\u20136.","journal-title":"Heart"},{"key":"481_CR37","doi-asserted-by":"crossref","first-page":"iv30","DOI":"10.1136\/heartjnl-2012-302400","volume":"98","author":"RK Binder","year":"2012","unstructured":"Binder RK, Webb JG. TAVI: from home-made prosthesis to global interventional phenomenon. Heart. 2012;98:iv30\u20136.","journal-title":"Heart"},{"key":"481_CR38","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1136\/hrt.2010.203661","volume":"96","author":"SW Grant","year":"2010","unstructured":"Grant SW, Devbhandari MP, Grayson AD, et al. What is the impact of providing a transcatheter aortic valve implantation service on conventional aortic valve surgical activity: patient risk factors and outcomes in the first 2 years. Heart. 2010;96:1633\u20137.","journal-title":"Heart"},{"key":"481_CR39","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ejcts.2010.11.031","volume":"40","author":"SC Malaisrie","year":"2011","unstructured":"Malaisrie SC, Tuday E, Lapin B, et al. Transcatheter aortic valve implantation decreases the rate of unoperated aortic stenosis. Eur J Cardiothorac Surg. 2011;40:43\u20138.","journal-title":"Eur J Cardiothorac Surg"},{"key":"481_CR40","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1161\/CIRCULATIONAHA.109.907402","volume":"122","author":"M Thomas","year":"2010","unstructured":"Thomas M, Schymik G, Walther T, et al. Thirty-day results of the SAPIEN aortic bioprosthesis European outcome (SOURCE) registry: a European registry of transcatheter aortic valve implantation using the Edwards SAPIEN Valve. Circulation. 2010;122:62\u20139.","journal-title":"Circulation"},{"key":"481_CR41","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1161\/CIRCULATIONAHA.110.001545","volume":"124","author":"M Thomas","year":"2011","unstructured":"Thomas M, Schymik G, Walther T, et al. One-year outcomes of cohort 1 in the Edwards SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) registry: the European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation. 2011;124:425\u201333.","journal-title":"Circulation"},{"key":"481_CR42","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1136\/heartjnl-2012-302876","volume":"98","author":"R Dworakowski","year":"2012","unstructured":"Dworakowski R, Wendler O. Optimal pain management after aortic valve implantation: an opportunity to improve outcomes after transapical access in the future? Heart. 2012;98:1541\u20132.","journal-title":"Heart"},{"key":"481_CR43","doi-asserted-by":"crossref","first-page":"iv44","DOI":"10.1136\/heartjnl-2012-302401","volume":"98","author":"S Stortecky","year":"2012","unstructured":"Stortecky S, Buellesfeld L, Wenaweser P, et al. Transcatheter aortic valve implantation: the procedure. Heart. 2012;98:iv44\u201351.","journal-title":"Heart"},{"key":"481_CR44","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1136\/heartjnl-2012-302185","volume":"98","author":"IJ Amat-Santos","year":"2012","unstructured":"Amat-Santos IJ, Dumont E, Villeneuve J, et al. Effect of thoracic epidural analgesia on clinical outcomes following transapical transcatheter aortic valve implantation. Heart. 2012;98:1583\u201390.","journal-title":"Heart"},{"key":"481_CR45","doi-asserted-by":"crossref","first-page":"617","DOI":"10.4244\/EIJV8I5A94","volume":"8","author":"CV Bourantas","year":"2012","unstructured":"Bourantas CV, Farooq V, Onuma Y, et al. Transcatheter aortic valve implantation: new developments and upcoming clinical trials. EuroIntervention. 2012;8:617\u201327.","journal-title":"EuroIntervention"},{"key":"481_CR46","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.jcin.2011.05.004","volume":"4","author":"M Mussardo","year":"2011","unstructured":"Mussardo M, Latib A, Chieffo A, et al. Periprocedural and short-term outcomes of transfemoral transcatheter aortic valve implantation with the Sapien XT as compared with the Edwards Sapien valve. JACC Cardiovasc Interv. 2011;4:743\u201350.","journal-title":"JACC Cardiovasc Interv"},{"key":"481_CR47","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/j.jtcvs.2012.11.051","volume":"145","author":"LG Svensson","year":"2013","unstructured":"Svensson LG, Tuzcu M, Kapadia S, et al. A comprehensive review of the PARTNER trial. J Thorac Cardiovasc Surg. 2013;145:S11\u2013S6.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"481_CR48","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1016\/j.jacc.2013.02.087","volume":"61","author":"RT Hahn","year":"2013","unstructured":"Hahn RT, Pibarot P, Stewart WJ, et al. Comparison of transcatheter and surgical aortic valve replacement in severe aortic stenosis: a longitudinal study of echo parameters in cohort A of the PARTNER trial. J Am Coll Cardiol. 2013;61:2514\u201321.","journal-title":"J Am Coll Cardiol"},{"key":"481_CR49","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1136\/heartjnl-2011-301203","volume":"98","author":"A Kempny","year":"2012","unstructured":"Kempny A, Diller G-P, Kaleschke G, et al. Impact of transcatheter aortic valve implantation or surgical aortic valve replacement on right ventricular function. Heart. 2012;98:1299\u2013304.","journal-title":"Heart"},{"key":"481_CR50","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1136\/heartjnl-2012-303296","volume":"99","author":"D Mesa","year":"2013","unstructured":"Mesa D, Castillo F, Ruiz Ortiz M, et al. Impact of transcatheter aortic valve implantation or surgical aortic valve replacement on right ventricular function. Heart. 2013;99:286.","journal-title":"Heart"},{"key":"481_CR51","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1136\/heartjnl-2012-302505","volume":"98","author":"R Dworakowski","year":"2012","unstructured":"Dworakowski R, Wendler O, Bhan A, et al. Successful transcatheter aortic valve implantation (TAVI) is associated with transient left ventricular dysfunction. Heart. 2012;98:1641\u20136.","journal-title":"Heart"},{"key":"481_CR52","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1136\/hrt.2010.217158","volume":"97","author":"M Abdel-Wahab","year":"2011","unstructured":"Abdel-Wahab M, Zahn R, Horack M, et al. Aortic regurgitation after transcatheter aortic valve implantation: incidence and early outcome. Results from the German transcatheter aortic valve interventions registry. Heart. 2011;97:899\u2013906.","journal-title":"Heart"},{"key":"481_CR53","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1136\/heartjnl-2012-301998","volume":"98","author":"P Gripari","year":"2012","unstructured":"Gripari P, Ewe SH, Fusini L, et al. Intraoperative 2D and 3D transoesophageal echocardiographic predictors of aortic regurgitation after transcatheter aortic valve implantation. Heart. 2012;98:1229\u201336.","journal-title":"Heart"},{"key":"481_CR54","doi-asserted-by":"crossref","first-page":"196","DOI":"10.2174\/157489012803832810","volume":"7","author":"S Neragi-Miandoab","year":"2012","unstructured":"Neragi-Miandoab S, Skripochnik E, Michler RE. Recently patented and widely used valves for transcatheter aortic valve implantation. Recent Pat Cardiovasc Drug Discov. 2012;7:196\u2013205.","journal-title":"Recent Pat Cardiovasc Drug Discov"},{"key":"481_CR55","doi-asserted-by":"crossref","first-page":"242","DOI":"10.4244\/EIJV4I2A43","volume":"4","author":"N Piazza","year":"2008","unstructured":"Piazza N, Grube E, Gerckens U, et al. Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) corevalve revalving system: results from the multicentre, expanded evaluation registry 1-year following CE mark approval. EuroIntervention. 2008;4:242\u20139.","journal-title":"EuroIntervention"},{"key":"481_CR56","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1161\/CIRCULATIONAHA.110.946533","volume":"123","author":"C Tamburino","year":"2011","unstructured":"Tamburino C, Capodanno D, Ramondo A, et al. Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis. Circulation. 2011;123:299\u2013308.","journal-title":"Circulation"},{"key":"481_CR57","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1136\/heartjnl-2011-300308","volume":"97","author":"R Bagur","year":"2011","unstructured":"Bagur R, Manazzoni JM, Dumont E, et al. Permanent pacemaker implantation following isolated aortic valve replacement in a large cohort of elderly patients with severe aortic stenosis. Heart. 2011;97:1687\u201394.","journal-title":"Heart"},{"key":"481_CR58","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1136\/heartjnl-2011-300065","volume":"98","author":"TA Fairbairn","year":"2012","unstructured":"Fairbairn TA, Mather AN, Bijsterveld P, et al. Diffusion-weighted MRI determined cerebral embolic infarction following transcatheter aortic valve implantation: assessment of predictive risk factors and the relationship to subsequent health status. Heart. 2012;98:18\u201323.","journal-title":"Heart"},{"key":"481_CR59","doi-asserted-by":"crossref","first-page":"iv37","DOI":"10.1136\/heartjnl-2012-302397","volume":"98","author":"BD Prendergast","year":"2012","unstructured":"Prendergast BD, Naber CK, Popma JJ. Transatlantic perspectives on TAVI: from essential infrastructure and integration to expansion, research and development. Heart. 2012;98:iv37\u201343.","journal-title":"Heart"},{"key":"481_CR60","first-page":"475","volume":"40","author":"P Astarci","year":"2011","unstructured":"Astarci P, Glineur D, Kefer J, et al. Magnetic resonance imaging evaluation of cerebral embolization during percutaneous aortic valve implantation: comparison of transfemoral and trans-apical approaches using Edwards Sapiens valve. Eur J Cardiothorac Surg. 2011;40:475\u20139.","journal-title":"Eur J Cardiothorac Surg"},{"key":"481_CR61","doi-asserted-by":"crossref","first-page":"43","DOI":"10.4244\/EIJV8I1A8","volume":"8","author":"CK Naber","year":"2012","unstructured":"Naber CK, Ghanem A, Abizaid AA, et al. First-in-man use of a novel embolic protection device for patients undergoing transcatheter aortic valve implantation. EuroIntervention. 2012;8:43\u201350.","journal-title":"EuroIntervention"},{"key":"481_CR62","doi-asserted-by":"crossref","first-page":"51","DOI":"10.4244\/EIJV8I1A9","volume":"8","author":"K Onsea","year":"2012","unstructured":"Onsea K, Agostoni P, Samim M, et al. First-in-man experience with a new embolic deflection device in transcatheter aortic valve interventions. EuroIntervention. 2012;8:51\u20136.","journal-title":"EuroIntervention"},{"key":"481_CR63","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.jcin.2010.05.022","volume":"3","author":"F Nietlispach","year":"2010","unstructured":"Nietlispach F, Wijesinghe N, Gurvitch R, et al. An embolic deflection device for aortic valve interventions. JACC Cardiovasc Interv. 2010;3:1133\u20138.","journal-title":"JACC Cardiovasc Interv"},{"key":"481_CR64","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/S0140-6736(09)60566-3","volume":"373","author":"H Krum","year":"2009","unstructured":"Krum H, Schlaich M, Whitbourn R, et al. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet. 2009;373:1275\u201381.","journal-title":"Lancet"},{"key":"481_CR65","doi-asserted-by":"crossref","unstructured":"Investigators SH-. Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months. Hypertension. 2011;57:911\u201317.","DOI":"10.1161\/HYPERTENSIONAHA.110.163014"},{"key":"481_CR66","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(10)62039-9","volume":"376","author":"MD Esler","year":"2010","unstructured":"Esler MD, Krum H, Sobotka PA, et al. Renal sympathetic denervation in patients with treatment-resistant hypertension (the Symplicity HTN-2 trial): a randomised controlled trial. Lancet. 2010;376:1903\u20139.","journal-title":"Lancet"},{"key":"481_CR67","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.1161\/CIRCULATIONAHA.112.130880","volume":"126","author":"MD Esler","year":"2012","unstructured":"Esler MD, Krum H, Schlaich M, et al. Renal sympathetic denervation for treatment of drug-resistant hypertension: one-year results from the Symplicity HTN-2 randomized, controlled trial. Circulation. 2012;126:2976\u201382.","journal-title":"Circulation"},{"key":"481_CR68","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1681\/ASN.2011111062","volume":"23","author":"D Hering","year":"2012","unstructured":"Hering D, Mahfoud F, Walton AS, et al. Renal denervation in moderate to severe CKD. J Am Soc Nephrol. 2012;23:1250\u20137.","journal-title":"J Am Soc Nephrol"},{"key":"481_CR69","unstructured":"Schofer J. REDUCE-HTN trial. EuroPCR. Paris, France: Euro PCR; 2013."},{"key":"481_CR70","unstructured":"Worthley SG. EnligHTN-1: BP drops durable, safe at one year, as renal-denervation mania grows. EuroPCR. Paris, France: heartwire; 2013."},{"key":"481_CR71","doi-asserted-by":"crossref","unstructured":"Templin C, Jaguszewski M, Ghadri JR, et al. Vascular lesions induced by renal nerve ablation as assessed by optical coherence tomography: pre- and post-procedural comparison with the Simplicity catheter system and the EnligHTN\u2122 multi-electrode renal denervation catheter. Eur Heart J. 2013 Apr 25. doi:10.1093\/eurheartj\/eht141. (Epub ahead of print).","DOI":"10.1093\/eurheartj\/eht141"},{"issue":"15","key":"481_CR72","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1136\/heartjnl-2012-301725","volume":"99","author":"S Ewen","year":"2013","unstructured":"Ewen S, Ukena C, B\u00f6hm M, et al. Percutaneous renal denervation: new treatment option for resistant hypertension and more? Heart. 2013","journal-title":"Heart"},{"key":"481_CR73","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1136\/heartjnl-2012-302569","volume":"98","author":"P Meier","year":"2012","unstructured":"Meier P, Timmis A. Almanac 2012: interventional cardiology: the national society journals present selected research that has driven recent advances in clinical cardiology. Heart. 2012;98:1701\u20139.","journal-title":"Heart"}],"container-title":["Wiener klinische Wochenschrift"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-013-0481-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00508-013-0481-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-013-0481-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T01:58:48Z","timestamp":1559095128000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00508-013-0481-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":73,"journal-issue":{"issue":"23-24","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["481"],"URL":"https:\/\/doi.org\/10.1007\/s00508-013-0481-5","relation":{},"ISSN":["0043-5325","1613-7671"],"issn-type":[{"value":"0043-5325","type":"print"},{"value":"1613-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12]]}}}